SE430752B - Sett att framstella vaccin mot newcastle-sjukan - Google Patents

Sett att framstella vaccin mot newcastle-sjukan

Info

Publication number
SE430752B
SE430752B SE7804116A SE7804116A SE430752B SE 430752 B SE430752 B SE 430752B SE 7804116 A SE7804116 A SE 7804116A SE 7804116 A SE7804116 A SE 7804116A SE 430752 B SE430752 B SE 430752B
Authority
SE
Sweden
Prior art keywords
strain
vaccine
infectious
aerosol
newcastle disease
Prior art date
Application number
SE7804116A
Other languages
English (en)
Swedish (sv)
Other versions
SE7804116L (sv
Inventor
J Gits
N Zygraich
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of SE7804116L publication Critical patent/SE7804116L/xx
Publication of SE430752B publication Critical patent/SE430752B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7804116A 1977-04-25 1978-04-12 Sett att framstella vaccin mot newcastle-sjukan SE430752B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE853923 1977-04-25

Publications (2)

Publication Number Publication Date
SE7804116L SE7804116L (sv) 1978-10-26
SE430752B true SE430752B (sv) 1983-12-12

Family

ID=3861522

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7804116A SE430752B (sv) 1977-04-25 1978-04-12 Sett att framstella vaccin mot newcastle-sjukan

Country Status (22)

Country Link
US (1) US4235876A (es)
AR (1) AR218304A1 (es)
AT (1) AT358166B (es)
BE (1) BE853923A (es)
CA (1) CA1113860A (es)
CH (1) CH641047A5 (es)
DE (1) DE2817891A1 (es)
DK (1) DK160878A (es)
FI (1) FI59535C (es)
FR (1) FR2388564A1 (es)
GB (1) GB1593567A (es)
HU (1) HU179290B (es)
IE (1) IE46943B1 (es)
IL (1) IL54390A (es)
IT (1) IT1113070B (es)
LU (1) LU79508A1 (es)
NL (1) NL7804182A (es)
NO (1) NO153010C (es)
PH (1) PH14085A (es)
PT (1) PT67868B (es)
SE (1) SE430752B (es)
ZA (1) ZA781832B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
US5118502A (en) * 1989-06-20 1992-06-02 The University Of Georgia Research Foundation, Inc. Naturally attenuated newcastle disease vaccine and method of using the same
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.
US5686077A (en) * 1991-09-20 1997-11-11 Akzo Nobel N.V. Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)
ES2188593T3 (es) * 1992-03-24 2003-07-01 United Cancer Res Inst Vacuna que contiene un virus vivo.
US5427791A (en) * 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
CA2181862C (en) * 1995-08-01 2009-12-22 Carla Christina Schrier Mild newcastle disease virus vaccine
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
HUP0202537A3 (en) 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
KR101481164B1 (ko) * 2008-01-30 2015-01-09 주식회사 미래셀바이오 체세포 유래 다능성 줄기세포의 제조 방법
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
US9956281B2 (en) 2011-05-04 2018-05-01 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767117A (en) * 1953-10-22 1956-10-16 Crawley John Frederick Poultry virus vaccine products and method of preparing the same
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
US3548054A (en) * 1969-06-06 1970-12-15 Lilly Co Eli Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines

Also Published As

Publication number Publication date
IT7822203A0 (it) 1978-04-11
NO781421L (no) 1978-10-26
PH14085A (en) 1981-02-10
FR2388564A1 (fr) 1978-11-24
CA1113860A (en) 1981-12-08
DK160878A (da) 1978-10-26
IE46943B1 (en) 1983-11-16
FI781233A (fi) 1978-10-26
FR2388564B1 (es) 1980-07-25
IL54390A (en) 1980-11-30
NO153010B (no) 1985-09-23
ZA781832B (en) 1979-03-28
NL7804182A (nl) 1978-10-27
HU179290B (en) 1982-09-28
IL54390A0 (en) 1978-06-15
ATA292278A (de) 1980-01-15
LU79508A1 (fr) 1978-09-29
AR218304A1 (es) 1980-05-30
BE853923A (fr) 1977-10-25
SE7804116L (sv) 1978-10-26
PT67868B (en) 1979-10-10
CH641047A5 (en) 1984-02-15
FI59535B (fi) 1981-05-29
GB1593567A (en) 1981-07-22
IT1113070B (it) 1986-01-20
FI59535C (fi) 1981-09-10
NO153010C (no) 1986-01-02
US4235876A (en) 1980-11-25
DE2817891A1 (de) 1978-11-09
IE780811L (en) 1978-10-25
AT358166B (de) 1980-08-25
PT67868A (en) 1978-05-01

Similar Documents

Publication Publication Date Title
SE430752B (sv) Sett att framstella vaccin mot newcastle-sjukan
DE60012042T2 (de) Entepneumovirus und entsprechendes impfstoff
US4122167A (en) Respiratory synctial vaccine
US4009258A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
US4053583A (en) Live newcastle disease virus vaccines
US4224412A (en) Living virus culture vaccine against canine distemper and method of preparing same
Gelb Jr et al. Serologic and cross-protection studies with several infectious bronchitis virus isolates from Delmarva-reared broiler chickens
CN108546302A (zh) 一种复合多表位表达盒、其组成的重组病毒及应用
Winterfield et al. Newcastle Disease Immunization Studies: 4. Vaccination of Chickens with B1, F and Lasota Strains of Newcastle Disease Virus Administered through the Drinking Water
HU226256B1 (en) A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
CN108018300A (zh) 区分免疫和感染动物h7亚型禽流感疫苗株及其制备方法和应用
CN104195116A (zh) 一种表达鹅细小病毒vp3基因的重组新城疫病毒及其构建方法
US4324861A (en) Preparation of live attenuated mumps virus for a vaccine
HU217214B (hu) Eljárás csirkeanémia-ágens vakcina előállítására
HU189222B (en) Process for preparing a new vaccine against infectious bronchytis
Maassab et al. Hybrid formation of influenza virus at 25
KR102154796B1 (ko) 변이 뉴캣슬병 바이러스 및 상기 바이러스를 이용한 조류 백신
De Jong et al. Antigenic heterogeneity within influenza A (H3N2) virus strains
US4145252A (en) Respiratory syncytial vaccine
NL8005577A (nl) Werkwijze voor het bereiden van een vaccin.
KR20020013378A (ko) 난내 투여용 ｉｂｄｖ 균주
PL177386B1 (pl) Kompozycja wirusowa do szczepionki do zapobiegania infekcyjnej chorobie torebek u drobiu,szczepionka do zapobiegania infekcyjnej chorobie torebek u drobiu oraz sposób otrzymywania szczepionki do zapobiegania infekcyjnej chorobie torebek u drobiu
KR102154795B1 (ko) 조류 인플루엔자 바이러스 h5n6의 표면항원을 발현하는 뉴캣슬병 바이러스 발현 시스템 및 이를 이용한 조류 백신
CN107384875A (zh) 克服雏鸡新城疫母源抗体影响的嵌合新城疫病毒载体h7活疫苗候选株及其构建方法
Chettle et al. Failure of maternally derived infectious bursal disease antibodies to serotypes 1 and 2 to protect against heterologous virus